Impact of catheter antimicrobial coating on species-specific risk of catheter colonization: A meta-analysis

Antimicrobial Resistance and Infection Control

Volumn 1, Issue , 2012, Pages

  Novikov, Aleksey ^a   Lam, Manuel Y ^a   Mermel, Leonard A ^a,b   Casey, Anna L ^c   Elliott, Tom S ^c   Nightingale, Peter ^c  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antimicrobial catheter; Bacteremia; Catheter colonization; Catheter related bloodstream infection; Central line associated bloodstream infection; Central venous catheter

Indexed keywords

CHLORHEXIDINE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE;

ACINETOBACTER; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CANDIDA ALBICANS; CENTRAL VENOUS CATHETER; CORYNEBACTERIUM DIPHTHERIAE; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; FUNGAL COLONIZATION; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MATERIAL COATING; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 84880886487     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-1-40     Document Type: Article

References (30)

1. Mermel LA. What is the predominant source of intravascular catheter infections?. Clin Infect Dis 2011, 52:211-212. 10.1093/cid/ciq108, 21288845.
2. Casey AL, Mermel LA, Nightingale P, Elliott TSJ. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:763-776. 10.1016/S1473-3099(08)70280-9, 19022192.
3. Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, Dündar Y, Gamble C, McLeod C, Walley T, Dickson R. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess 2008, 12:1-154.
4. Wang H, Huang T, Jing J, Jin J, Wang P, Yang M, Cui W, Zheng Y, Shen H. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J Hosp Infect 2010, 76:1-11. 10.1016/j.jhin.2010.04.025, 20638155.
5. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997, 127:257-266.
6. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis 1980, 141:781-786. 10.1093/infdis/141.6.781, 6993589.
7. Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napolitano LM, Edwards LP, O'Connell FM, Puyana JC, Doern GV. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998, 158:81-87.
8. Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta JM, Mermel LA, Lee D, Dellinger EP, Donahoe M, Giles D, Pfaller MA, Maki DG, Sherertz R. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005, 143:570-580.
9. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997, 127:267-274.
10. Goldschmidt H, Hahn U, Salwender HJ, Haas R, Jansen B, Wolbring P, Rinck M, Hunstein W. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients. Zentralbl. Bakteriol 1995, 283:215-223. 10.1016/S0934-8840(11)80203-3, 8825113.
11. Bach AA, Schmidt HH, Böttiger BB, Schreiber BB, Böhrer HH, Motsch JJ, Martin EE, Sonntag HGH. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996, 37:315-322. 10.1093/jac/37.2.315, 8707741.
12. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996, 62:641-646.
13. van Heerden PV, Webb SA, Fong S, Golledge CL, Roberts BL, Thompson WR. Central venous catheters revisited-infection rates and an assessment of the new Fibrin Analysing System brush. Anaesth Intensive Care 1996, 24:330-333.
14. Bach A, Eberhardt H, Frick A, Schmidt H, Böttiger BW, Martin E. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med 1999, 27:515-521. 10.1097/00003246-199903000-00028, 10199530.
15. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999, 115:1632-1640. 10.1378/chest.115.6.1632, 10378561.
16. Hannan M, Juste RN, Umasanker S, Glendenning A, Nightingale C, Azadian B, Soni N. Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia 1999, 54:868-872. 10.1046/j.1365-2044.1999.01000.x, 10460558.
17. Marik PE, Abraham G, Careau P, Varon J, Fromm RE. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999, 27:1128-1131. 10.1097/00003246-199906000-00034, 10397217.
18. Sheng WH, Ko WJ, Wang JT, Chang SC, Hsueh PR, Luh KT. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis 2000, 38:1-5. 10.1016/S0732-8893(00)00166-8, 11025176.
19. Jaeger K, Osthaus A, Heine J, Ruschulte H, Kuhlmann C, Weissbrodt H, Ganser A, Karthaus M. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients. Chemotherapy 2001, 47:50-55. 10.1159/000048501, 11125233.
20. Corral L, Nolla-Salas M, Ibañez-Nolla J, León MA, Díaz RM, Cruz Martín M, Iglesia R, Catalan R. A prospective, randomized study in critically ill patients using the Oligon Vantex catheter. J Hosp Infect 2003, 55:212-219. 10.1016/j.jhin.2003.07.001, 14572489.
21. Brun-Buisson C, Doyon F, Sollet J-P, Cochard J-F, Cohen Y, Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med 2004, 30:837-843. 10.1007/s00134-004-2221-9, 15060765.
22. León C, Ruiz-Santana S, Rello J, La Torre De MV, Vallés J, Alvarez-Lerma F, Sierra R, Saavedra P, Alvarez-Salgado F. Cabaña Study Group: benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 2004, 30:1891-1899. 10.1007/s00134-004-2378-2, 15278273.
23. Yücel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Pulverer G, Neugebauer EAM. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. J Antimicrob Chemother 2004, 54:1109-1115. 10.1093/jac/dkh483, 15537696.
24. Dünser MW, Mayr AJ, Hinterberger G, Flörl CL, Ulmer H, Schmid S, Friesenecker B, Lorenz I, Hasibeder WR. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters. Anesth Analg 2005, 101:1778-1784.
25. Osma S, Kahveci SF, Kaya FN, Akalin H, Ozakin C, Yilmaz E, Kutlay O. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit. J Hosp Infect 2006, 62:156-162. 10.1016/j.jhin.2005.06.030, 16307824.
26. Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant J-Y, Eyraud D, Lherm T, Santoli F, Naija W, Riou B. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 2007, 35:1032-1039. 10.1097/01.CCM.0000259378.53166.1B, 17334256.
27. Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 2001, 22:640-646. 10.1086/501836, 11776351.
28. Gaonkar TA, Modak SM. Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model. J Antimicrob Chemother 2003, 52:389-396. 10.1093/jac/dkg361, 12917250.
29. Yorganci K, Krepel C, Weigelt JA, Edmiston CE. Activity of antibacterial impregnated central venous catheters against Klebsiella pneumoniae. Intensive Care Med 2002, 28:438-442. 10.1007/s00134-002-1243-4, 11967598.
30. Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, Chaftari AM, Hachem RY. Improved antibiotic-impregnated catheters with extended- spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother 2012, 56:935-941. 10.1128/AAC.05836-11, 3264266, 22123686.